Deciphera Pharmaceuticals Inc (DCPH)
25.45
+0.01
(+0.04%)
USD |
NASDAQ |
May 15, 14:15
Deciphera Pharmaceuticals Total Assets (Quarterly): 420.93M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 420.93M |
| December 31, 2023 | 473.57M |
| September 30, 2023 | 497.84M |
| June 30, 2023 | 509.62M |
| March 31, 2023 | 549.02M |
| December 31, 2022 | 454.04M |
| September 30, 2022 | 475.95M |
| June 30, 2022 | 507.04M |
| March 31, 2022 | 385.46M |
| December 31, 2021 | 429.48M |
| September 30, 2021 | 483.42M |
| June 30, 2021 | 540.57M |
| March 31, 2021 | 595.25M |
| December 31, 2020 | 642.43M |
| September 30, 2020 | 659.67M |
| Date | Value |
|---|---|
| June 30, 2020 | 686.30M |
| March 31, 2020 | 732.93M |
| December 31, 2019 | 622.41M |
| September 30, 2019 | 649.60M |
| June 30, 2019 | 260.01M |
| March 31, 2019 | 269.69M |
| December 31, 2018 | 315.56M |
| September 30, 2018 | 345.92M |
| June 30, 2018 | 368.16M |
| March 31, 2018 | 182.14M |
| December 31, 2017 | 199.10M |
| September 30, 2017 | 87.87M |
| June 30, 2017 | 97.06M |
| December 31, 2016 | 58.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
260.01M
Minimum
Jun 2019
732.93M
Maximum
Mar 2020
528.78M
Average
508.33M
Median
Total Assets (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 99.03B |
| Dynavax Technologies Corp | 986.56M |
| Gilead Sciences Inc | 56.29B |
| Esperion Therapeutics Inc | 373.06M |
| SINTX Technologies Inc | 15.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 104.88M |
| Shareholders Equity (Quarterly) | 316.05M |
| Current Ratio | 4.194 |